- Luckin Coffee Q2 net revenue reached 15.89 billion RMB, up 29% year-over-year, exceeding the estimated 15.43 billion RMB. Q2 net profit was 1.49 billion RMB, a year-over-year increase of 19%. Adjusted net earnings per ADS for Q2 were 5.44 RMB.
- Bernstein raises Apple (AAPL.US) target price from $350 to $370.
- Star Bulk COO Nikolaos Reskos sells 5,000 common shares worth $144,950
- ADIAL PHARMACEUTICALS INC : ALLIANCE GLOBAL PARTNERS INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $11
- PBF ENERGY INC : JP MORGAN RAISES TARGET PRICE TO $83 FROM $57
- DOORDASH <DASH.O>: BENCHMARK CUTS TARGET PRICE TO $270 FROM $285
- Spot platinum has just broken through the $1,640.00/oz mark, last trading at $1,639.90/oz, down 0.20% on the day; Nymex platinum futures for the main contract are last quoted at $1,648.0/oz, down 0.65% on the day.
- BRIEF-Avista Q2 EPS USD 0.43
- CORNING <GLW.N>: TRUIST SECURITIES RAISES TO BUY FROM HOLD; CUTS TARGET PRICE TO $175 FROM $205
- GALAXY DIGITAL INC <GLXY.O>: ROSENBLATT SECURITIES CUTS TARGET PRICE TO $35 FROM $39
- Regenxbio schedules conference call to discuss second-quarter results and operational update
- WEYERHAEUSER CO <WY.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $28 FROM $27
- SPX TECHNOLOGIES INC <SPXC.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $301 FROM $295
- Autolus enters up to USD 250 million senior secured notes facility with Perceptive Credit Holdings V
- Two Harbors says CCM merger wins approvals in all but one state
- Compugen Q2 FY26 net loss narrows to USD 7 million; revenue more than doubled to USD 2.6 million
- QUANTA SERVICES INC : TRUIST SECURITIES RAISES TARGET PRICE TO $976 FROM $940
- InMode holds annual shareholder meeting
- APPLE INC : BERNSTEIN RAISES TARGET PRICE TO $370 FROM $350
- QUAKER HOUGHTON <KWR.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $190 FROM $172
- BioXcel Therapeutics amends Oaktree-led credit agreement, defers loan payment to Aug. 31
- Luckin Coffee Q2 FY26 net income climbs 16.1% to RMB 1.49 billion; total net revenues rise 28.5% to RMB 15.89 billion
- PITNEY BOWES INC : TRUIST SECURITIES RAISES TARGET PRICE TO $18 FROM $15
- Wayfair plans first Pennsylvania store in Pittsburgh, opening in 2027
- Ceribell wins CMS NTAP for delirium monitor, worth up to $2,171 per Medicare case
- Green Thumb Industries to present at Canaccord Genuity Growth Conference
- CIBC restates Q2 2026 financial results after Final Terms omission error
- Palomino names Karthik Gopalakrishnan CTO, Rajesh Radhamohan CPO
- Marex completes acquisition of equity derivatives market maker Webb Traders
- Krystal Biotech 2Q Rev $119.2M >KRYS
- Marriott Sees 2026 Adjusted Ebitda $5.965B-$6.025B >MAR
- Marriott Sees 2026 Investment Spending $1.25B-$1.35B >MAR
- NEUROCRINE BIOSCIENCES, INC <NBIX.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $213 FROM $200
- MASTEC INC <MTZ.N>: TRUIST SECURITIES CUTS TARGET PRICE TO $428 FROM $550
- TG Therapeutics Q2 net income drops to $7.8 million; revenue rises 70.26% to $240.3 million
- Aspen Pharmacare updates financial calendar with upcoming annual results release and webcast presentation
- EXPEDIA GROUP INC <EXPE.O>: TRUIST SECURITIES RAISES TARGET PRICE TO $309 FROM $246
- Can-Fite submits Phase 2 Lowe syndrome trial protocol for Piclidenoson to Italy hospital
- Z Squared agrees to buy Paradox Data, expands deal to 100% acquisition
- Air Industries extends Tenax Aerospace merger outside date to Nov. 30, 2026
- Ocular Therapeutix Q2 FY26 net loss widens to $78.76 million; revenue rises 0.12% to $13.48 million
- CSW INDUSTRIALS INC <CSW.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $332 FROM $313
- Seaport Therapeutics 2Q Research and Development Expenses Were $24.6M >SPTX
- Ellington Credit Company updates financial calendar with earnings release and conference call schedule
- ALNYLAM PHARMACEUTICALS INC : BERNSTEIN CUTS TARGET PRICE TO $376 FROM $429
- Sportradar turns to Q2 FY26 net loss of €4 million; revenue rises 19% to €378 million
- Chevron expands North America base oils distribution via HF Sinclair, Renkert Oil deals
- Klappir Green Solutions calls extraordinary shareholders meeting
- Trump Intensifies Foreign Policy and Intervention Signals; U.S.-Iran Talks Imminent and U.S.-Japan Joint Market Support Draws Attention
- Seaport Therapeutics 2Q Loss/Shr $1.78 >SPTX
- Marriott Sees 3Q Adjusted Ebitda $1.44B-$1.47B >MAR
- Oil Prices Fall to Three-week Low After Trump Calls off Planned Attack
- Dow Jones Top Company Headlines at 7 AM ET: AstraZeneca Shares Drop, Bristol Myers Squibb's Climb After Merger Talks Reports | Banco ...
- Marriott 2Q Comparable System-Wide Intl Constant Dollar RevPAR Down 0.5% >MAR
- Marriott Sees FY Adj EPS $11.64-Adj EPS $11.81 >MAR
- Marriott Sees 3Q Adj EPS $2.74-Adj EPS $2.82 >MAR
- Marriott 2Q EPS $2.90 >MAR
- Air Industries Group Announces Amendment, Extending The Amended And Restated Merger Agreement With Tenax Aerospace >airi
- TG Therapeutics 2Q EPS 5c >TGTX
- BRIEF-Douglas Dynamics Q2 Adjusted EPS USD 1.22 Vs. IBES Estimate USD 1.07
- ENAV H1 FY26 net profit rises to EUR 20.1 million; revenue increases 7.4% to EUR 479.8 million
- Douglas Dynamics Q2 FY26 diluted EPS slips 1.83% to $1.07; net sales rise 10% to $214.6 million
- DEFINITY FINANCIAL CORP <DFY.TO>: BMO RAISES TARGET PRICE TO C$83 FROM C$80
- Douglas Dynamics 2Q Net $25.4M >PLOW
- Douglas Dynamics 2Q Adj EPS $1.22 >PLOW
- Douglas Dynamics 2Q Sales $214.6M >PLOW
- CORTEVA <CTVA.N>: BMO RAISES TARGET PRICE TO $100 FROM $95
- RTX CORP <RTX.N>: BERNSTEIN RAISES TARGET PRICE TO $232 FROM $213
- Eurozone Manufacturing Recovery Looks Shaky -- Market Talk
- EQUINOX GOLD CORP <EQX.TO>: BMO RESUMES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE C$21 VS C$26
- VF CEO Darrell Bracken acquires 32,894 VF common shares for $492,746.12
- L3HARRIS TECHNOLOGIES, INC <LHX.N>: BERNSTEIN CUTS TARGET PRICE TO $365 FROM $405
- FORTIS INC <FTS.TO>: BMO RAISES TARGET PRICE TO C$83 FROM C$79
- GEORGE WESTON LTD <WN.TO>: BMO RAISES TARGET PRICE TO C$121 FROM C$113
- Japan dumped $34 billion last Friday to rescue the yen! This round of intervention may reach a record high for a single month
- Algerian state oil company: On Sunday, an uncontrolled natural gas leak occurred at well TG 16 of the Tiguentourine gas field in Algeria during maintenance. No casualties were reported.
- Brookfield completes acquisition of Oaktree
- TELUS CORPORATION <T.TO>: BMO CUTS TARGET PRICE TO C$15 FROM C$19
- CHEVRON CORP <CVX.N>: BERNSTEIN RAISES TARGET PRICE TO $209 FROM $204
- NASDAQ TRADE HALT <SMTK.O> HALT NEWS PENDING AT 06:55 AM
- CAMECO CORP <CCO.TO>: BERNSTEIN RAISES TARGET PRICE TO C$189 FROM C$188
- ALLIANT ENERGY CORP <LNT.O>: BMO CUTS TARGET PRICE TO $78 FROM $80
- WINGSTOP INC <WING.O>: BERNSTEIN CUTS TO MARKET PERFORM FROM OUTPERFORM; CUTS TARGET PRICE TO $155 FROM $220
- T ROWE PRICE GROUP INC <TROW.O>: BMO RAISES TARGET PRICE TO $120 FROM $110
- Gravis flags “generation rent” as UK real estate demand driver through 2030
- ARES MANAGEMENT CORP : BMO RAISES TARGET PRICE TO $134 FROM $128
- Procore plans private placement of USD 750 million convertible senior notes due 2031
- Procore plans private placement of USD 750 million convertible senior notes due 2031
- Eton Pharma to report Q2 2026 results, host conference call and webcast
- PJT PARTNERS INC : BMO RAISES TARGET PRICE TO $194 FROM $183
- Neinor Homes buys back 22,500 shares at average price EUR 15.73 under stabilization program
- Sally Beauty Holdings Narrows FY26 View To Adj EPS $2.04-Adj EPS $2.08 >SBH
- WELLTOWER INC <WELL.N>: BMO RAISES TARGET PRICE TO $265 FROM $245
- VENTAS INC <VTR.N>: BMO RAISES TARGET PRICE TO $105 FROM $100
- Sally Beauty Holdings Narrows FY26 View To Sales $3.725B-$3.733B >SBH
- Sally Beauty Holdings 3Q Adj EPS 55c >SBH
- BRIEF-Sally Beauty Q3 Adjusted EPS USD 0.55 Vs. IBES Estimate USD 0.53
- Sally Beauty FY26 Q3 GAAP diluted EPS rises 25% to $0.55; net sales increase 0.2% to $935 million
- COUSINS PROPERTIES INC <CUZ.N>: BMO RAISES TARGET PRICE TO $35 FROM $31
- Brookfield Asset Management completes acquisition of Oaktree
